Zhou Hua, Wong Yuen Fan, Cai Xiong, Liu Zhong Qiu, Jiang Zhi Hong, Bian Zhao Xiang, Xu Hong Xi, Liu Liang
School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
Biol Pharm Bull. 2006 Feb;29(2):253-60. doi: 10.1248/bpb.29.253.
JCICM-6, the extract of an anti-arthritic herbal formula composed of medicinal herbs of Sinomenium acutum, Aconitum carmichaeli DEBX., Curcuma Longa L., Paeonia lactiflora PALL., and Paeonia suffruticosa ANDR., was examined in the effectiveness and mechanism in reducing experimentally-induced inflammation and nociception using nine animal models. JCICM-6 was extracted from herbs and purified with Amberlite XAD-7HP adsorbent resin and analyzed with HPLC-fingerprint for quality consistency. In acute inflammatory models, the paw edema of rats was induced by subcutaneous injection of carrageenan or pro-inflammatory mediators, including histamine, serotonin, bradykinin, and prostaglandin E(2) (PGE(2)) into the right hind paws of animals; while the ear edema of mice was induced by applying arachidonic acid or 12-O-tetradecanoylphorbol 13-acetate (TPA) on the ear surface. In nociceptive models, the tail-flick response induced by radiant heat stimulation was measured and the numbers of abdominal writhing episodes of mice induced by intraperitoneal injection of acetic acid were recorded. JCICM-6 orally administered in a range of dosages from 0.438 g to 1.75 g/kg significantly and dose-dependently suppressed the paw edema of rats induced by carrageenan or various pro-inflammatory mediators and the ear edema of mice induced by arachidonic acid or TPA. JCICM-6 also significantly prolonged the reaction time of rats to radiant heat stimulation and reduced the numbers of writhing episodes of mice. These results indicated that JCICM-6 possesses significant anti-inflammatory and analgesic effects, which implies that it would be a potential candidate for further investigation as a new anti-arthritic botanical drug for humans.
JCICM - 6是一种抗关节炎草药配方的提取物,该配方由青风藤、制川乌、姜黄、白芍和牡丹皮组成。使用九种动物模型研究了JCICM - 6在减轻实验性诱导的炎症和痛觉方面的有效性和作用机制。JCICM - 6从草药中提取,并用Amberlite XAD - 7HP吸附树脂纯化,通过高效液相色谱指纹图谱分析其质量一致性。在急性炎症模型中,通过皮下注射角叉菜胶或促炎介质(包括组胺、5 - 羟色胺、缓激肽和前列腺素E2(PGE2))诱导大鼠右后爪爪水肿;而通过在小鼠耳部表面涂抹花生四烯酸或12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)诱导小鼠耳部水肿。在痛觉模型中,测量辐射热刺激诱导的甩尾反应,并记录腹腔注射乙酸诱导的小鼠腹部扭体发作次数。以0.438 g至1.75 g/kg的一系列剂量口服JCICM - 6可显著且剂量依赖性地抑制角叉菜胶或各种促炎介质诱导的大鼠爪水肿以及花生四烯酸或TPA诱导的小鼠耳部水肿。JCICM - 6还显著延长了大鼠对辐射热刺激的反应时间,并减少了小鼠的扭体发作次数。这些结果表明JCICM - 6具有显著的抗炎和镇痛作用,这意味着它作为一种新型抗关节炎植物药用于人类进一步研究具有潜在的可能性。